6-K ·Filed Jul 17, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago SEC0001654954-26-006706
Notable filing: 6-K
Actionable Insight • Neutral

No near-term trading implications. The audit re-appointment is procedural and does not affect earnings, cash flow, or business strategy. Monitor the 2028 AGM for approval, but this filing is non-event for stock price.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
GSK ▼ -4.33% at T+20d
NEUTRAL call ✗ call lost -4.33% · α vs SPY -8.77% · entry $51.76 → $49.52
Next anchor: T+60d in 10d
Latest observation: T+51 +11.09% FF3 residual α
Entry anchored
Jul 16, 03:59 PM ET
via exchange tick
T+1d
-3.32%
call -3.32% · α -3.16%
$50.04
settled 2mo ago
T+5d
-1.97%
call -1.97% · α -1.28%
$50.74
settled 2mo ago
T+20d
-4.33%
call -4.33% · α -8.77%
$49.52
settled 7w ago
T+60d
—
call — · α —
—
in 10d

Price Chart

Loading chart...

Executive Summary

GSK announced the re-appointment of Deloitte LLP as its external auditor effective from the financial year ending December 31, 2028, following a competitive tender process led by the Audit & Risk Committee. This is a routine governance matter required by Public Interest Entity rules and carries no material financial or operational implications.

Key Facts

  • Board re-appointed Deloitte LLP as external auditor for financial year ending Dec 31, 2028
  • Tender process required every 10 years; rotation every 20 years per PIE rules
  • Deloitte initially appointed for FY ended Dec 31, 2018
  • Re-appointment subject to shareholder approval at 2028 AGM

Financial Impact

No material financial impact

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
43% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-006706
Document: 0001654954-26-006706-index-headers.html0001654954-26-006706
Document: 0001654954-26-006706-index.html0001654954-26-006706
Document: 0001654954-26-006706.txt0001654954-26-006706
42 reports for GSK
Performance horizon
69% Hit rate 11 of 16 directional calls best @ T+60▲ +7.85%Jun 16, 2026
Filters
Rows
Reports for GSK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 5/10
$50.01 $50.22▲ +0.42%▼ −0.40%$47.03 (−5.96%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 1/10
$48.13 $50.22▲ +4.34%▲ +4.56%$47.03 (−2.29%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 1/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 6/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 1/10
$51.43 $50.44▼ −1.92%▼ −1.80%$47.03 (−8.56%)
Aug 24, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$51.78 $50.25▼ −2.95%▼ −3.42%$47.03 (−9.17%)
Showing 10 of 42

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access